Fate Therapeutics
FATE
#8997
Rank
โ‚น13.41 B
Marketcap
โ‚น115.38
Share price
-2.36%
Change (1 day)
45.50%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: โ‚น13.41 Billion

As of April 2026 Fate Therapeutics has a market cap of โ‚น13.41 Billion. This makes Fate Therapeutics the world's 8997th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น13.41 B29.54%
2025โ‚น10.35 B-34.17%
2024โ‚น15.73 B-48.76%
2023โ‚น30.69 B-62.16%
2022โ‚น81.13 B-80.49%
2021โ‚น415.86 B-28.32%
2020โ‚น580.17 B448.97%
2019โ‚น105.68 B82.1%
2018โ‚น58.03 B182.61%
2017โ‚น20.53 B190.92%
2016โ‚น7.05 B9.76%
2015โ‚น6.43 B-1.92%
2014โ‚น6.55 B-17.29%
2013โ‚น7.92 B

End of Day market cap according to different sources

On Apr 12th, 2026 the market cap of Fate Therapeutics was reported to be:

โ‚น13.41 Billion
by Nasdaq info icon info icon
โ‚น13.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
โ‚น5.198 T 38,655.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น206.90 B 1,442.44%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น529.05 B 3,843.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.203 T 8,872.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น1.046 T 7,702.88%๐Ÿ‡บ๐Ÿ‡ธ USA